Literature DB >> 776856

The bactericidal effect of rifampicin on M. leprae in man: a) single doses of 600, 900 and 1200 mg; and b) daily doses of 300 mg.

L Levy, C C Shepard, P Fasal.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 776856

Source DB:  PubMed          Journal:  Int J Lepr Other Mycobact Dis        ISSN: 0148-916X


× No keyword cloud information.
  16 in total

1.  Comparative modeling of UDP-N-acetylmuramoyl-glycyl-D-glutamate-2, 6-diaminopimelate ligase from Mycobacterium leprae and analysis of its binding features through molecular docking studies.

Authors:  Anusuya Shanmugam; Jeyakumar Natarajan
Journal:  J Mol Model       Date:  2011-04-15       Impact factor: 1.810

2.  High relapse rate among lepromatous leprosy patients treated with rifampin plus ofloxacin daily for 4 weeks.

Authors:  B Ji; P Jamet; S Sow; E G Perani; I Traore; J H Grosset
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

3.  Bactericidal activity of a single-dose combination of ofloxacin plus minocycline, with or without rifampin, against Mycobacterium leprae in mice and in lepromatous patients.

Authors:  B Ji; S Sow; E Perani; C Lienhardt; V Diderot; J Grosset
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

4.  Homology modeling and docking analyses of M. leprae Mur ligases reveals the common binding residues for structure based drug designing to eradicate leprosy.

Authors:  Anusuya Shanmugam; Jeyakumar Natarajan
Journal:  J Mol Model       Date:  2011-11-19       Impact factor: 1.810

5.  Treating Hansen's disease in developing countries.

Authors:  S S Vasireddi
Journal:  West J Med       Date:  1994-03

Review 6.  Treatment of leprosy in the United States.

Authors:  W R Levis
Journal:  Bull N Y Acad Med       Date:  1984-09

Review 7.  Clinical pharmacokinetic considerations in the treatment of patients with leprosy.

Authors:  K Venkatesan
Journal:  Clin Pharmacokinet       Date:  1989-06       Impact factor: 6.447

8.  Bactericidal activities of combinations of new drugs against Mycobacterium leprae in nude mice.

Authors:  B Ji; E G Perani; C Petinom; J H Grosset
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

9.  Radiometric macrophage culture assay for rapid evaluation of antileprosy activity of rifampin.

Authors:  A Mittal; P S Seshadri; H K Prasad; M Sathish; I Nath
Journal:  Antimicrob Agents Chemother       Date:  1983-10       Impact factor: 5.191

10.  Changes in cellular response to mycobacterial antigens and cytokine production patterns in leprosy patients during multiple drug therapy.

Authors:  V T Trao; P L Huong; A T Thuan; D D Anh; D D Trach; G A Rook; E P Wright
Journal:  Immunology       Date:  1998-06       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.